50090-1523 GARDASIL - CanMED: NDC

Product NDC:

50090-1523

Brand Name:

GARDASIL

Generic Name:

Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant

Human Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant

Dosage Form Name:

INJECTION, SUSPENSION

Administration Route:

Intramuscular

Substances:

Name: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN

Strength: 40.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN

Strength: 40.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN

Strength: 20.0

Unit: ug/.5mL

Name: HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN

Strength: 20.0

Unit: ug/.5mL

Packages:

Code: 50090-1523-01

Description: 10 VIAL, SINGLE-DOSE in 1 CARTON (50090-1523-1) > .5 mL in 1 VIAL, SINGLE-DOSE (50090-1523-9)

Effective Date: June 8, 2006

Discontinued:

Code: 50090-1523-09

Description:

Effective Date: June 8, 2006

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Protective Agent

Minor Class:

HPV Vaccine

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox